Loading...

Archive

    02 November 2019, Volume 35 Issue 11 Previous Issue    Next Issue

    For Selected: Toggle Thumbnails
    Pregnancy risk and mode of delivery in pregnant women with heart disease.
    WU Jian-li,ZHU Qi-ying
    2019, 35(11): 1193-1196.  DOI: 10.19538/j.fk2019110103
    Abstract ( )  

    Pregnancy with heart disease is one of the important causes of maternal mortality.Assessment and management of such patients before pregnancy, during pregnancy and during childbirth play an important role in reducing maternal mortality and improving maternal and infant outcomes.This article summarizes the risk assessment of pregnancy with heart disease and the choice of delivery mode at home and abroad in order to provide reference for clinical workers in diagnosis, treatment and management of pregnancy with heart disease.

    Management of ventricular arrhythmias in pregnancy.
    MA Yu-yan,LU Rui-hui
    2019, 35(11): 1196-1199.  DOI: 10.19538/j.fk2019110104
    Abstract ( )  

    Ventricular arrhythmias in pregnancy is a common disease of cardiovascular disease during pregnancy which can cause adverse outcomes in severe state,such as maternal heart failure,sudden death,fetal hypoxia,premature delivery and stillbirth.The management of ventricular arrhythmias requires multidisciplinary participation,including obstetrics,cardiology,anesthesiology and neonatology.This article discusses how to manage the ventricular arrhythmias from the following aspects:pre-pregnancy counseling and assessment,treatments,managements during pregnancy and managements of delivery in order to reduce the occurrence of maternal and fetal complications,and emphasizes the significance of multidisciplinary collaborative management to the prognosis of disease.

    Management of pregnancy with pulmonary arterial hypertension.
    ZHU Xiao-wen, HAN Feng-zhen
    2019, 35(11): 1200-1204.  DOI: 10.19538/j.fk2019110105
    Abstract ( )  

    Pulmonary arterial hypertension is a severe complication in pregnant women and poses a significant risk to mother and fetus.We post an introduction in the diagnosis and clinical classification of PAH,risk assessment of pregnancy,gestation and postpartum management of common classification.Standardized assessment and treatment in the corresponding medical institutions helps to improve the prognosis of mothers and infants in pregnancy with pulmonary hypertension.

    Comprehensive management of pregnancy in women with congenital heart disease.
    CHEN Peng-zheng,LI Lei
    2019, 35(11): 1205-1210.  DOI: 10.19538/j.fk2019110106
    Abstract ( )  

    There are an increasing number of women with CHD seeking to bear children,and once pregnant,the risk of heart and maternal and fetal complications increases,and heart function is furhter damaged.The risk depends on the type of congenital heart disease,degree of hemodynamic impairment,and potential complications.Strengthening the comprehensive management of such patients,conducting careful individual and multidisciplinary risk assessment,and formulating detailed plans for follow-up during pregnancy,delivery and postpartum treatment can reduce the risk and improve perinatal outcomes,which has important significance for reducing maternal mortality.

    Risk and management strategy of pregnancy after valve replacement for rheumatic heart disease.
    LIU Shi-ping,CHEN Qian
    2019, 35(11): 1210-1213.  DOI: 10.19538/j.fk2019110107
    Abstract ( )  

    Pregnancy after valve replacement for rheumatic heart disease is a high-risk pregnancy.There are risks of valve thrombosis, anticoagulation-related complications, prosthetic valve dysfunction and prosthetic valve endocarditis.Comprehensive preconception evaluation and strict management should be carried out in order to reduce maternal and neonatal complications.

    Prevention and treatment of preeclampsia complicated with cardiac insufficiency.
    PENG Ting,LI Xiao-tian
    2019, 35(11): 1213-1217.  DOI: 10.19538/j.fk2019110108
    Abstract ( )  

    Complication with twins or hypoproteinemia and long-term use of fetal protection drugs and other factors in preeclampsia pregnant women significantly increase the risk of heart failure.Combining typical clinical manifestations with auxiliary examinations can diagnose preeclampsia complicated with cardiac insufficiency.The early symptoms of cardiac insufficiency are easy to be neglected.We should pay attention to the manifestations of early heart failure.Active control of preeclampsia and timely termination of pregnancy are the main measures to prevent cardiac insufficiency.Preeclampsia is also a major risk factor for long-term cardiovascular complications.It is necessary to synthesize multidisciplinary diagnosis and treatment and strengthen long-term follow-up.

    Choice of anesthesia for pregnancy with heart disease.
    2019, 35(11): 1217-1220.  DOI: 10.19538/j.fk2019110109
    Abstract ( )  

    Pregnancy with heart disease is one of the serious complications of obstetric diseases,which is the main cause of maternal and neonatal death in perioperative period.The choice of anesthesia for pregnancy with heart disease is mainly based on the condition of the mother and the condition of the fetus in the uterus.Regardless of the choice of anesthesia,the maternal vital signs should be stabilized and the safety of the newborn is the most important thing.This article describes these contents,with a view to guide clinical practice and achieve safe anesthesia.

    Peripartum management of pregnancy with congenital heart disease.
    HU Xiao-jing,QI Hong-bo
    2019, 35(11): 1220-1224.  DOI: 10.19538/j.fk2019110110
    Abstract ( )  

    The survival rate of adult patients with congenital heart disease(CHD)has increased during the last few decades as a result of significant improvement in diagnosis and treatment.Women with CHD are therefore more likely to live to childbearing age,and to decide to have children.Compared with the general parturients,maternal risk and neonatal complications such as prematurity,intra-uterine fetal growth restriction,fetal demise,or neonatal mortality,are increased in pregnant women with CHD.How can we minimize the maternal mortality and morbidity risk and improve perinatal outcome?We retrospectively reviewed articles and documents about pregnancy with congenital heart disease,and tried to discuss it in this article.

    Diagnosis and treatment of peripartum cardiomyopathy.
    LIU Yan-yan,FENG Ling
    2019, 35(11): 1224-1228.  DOI: 10.19538/j.fk2019110111
    Abstract ( )  

    Typical symptoms of peripartum cardiomyopathy(PPCM)are heart failure and dyspnea.Echocardiography is the first choice.Bromocriptine and oral drugs for heart failure are the main treatments.For pregnant women with heart failure with hemodynamic instability,pregnancy should be terminated regardless of the size of the gestational age.The predictors of maternal mortality are NYHA class Ⅲ/Ⅳ and left ventricular ejection fraction(LVEF)<40%.